On the stock market since 2021, it operates in the world of heavy industry. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
No real growth (3% a year). Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
An investor who bought at the very peak is down 63% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Sales run at $62.6M a year. A small number, but proof the product has real buyers.
A loss of $375K against $62.6M in annual sales.
The stock sits at $0.45. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
On our five-subject report card, APEUF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: APEUF is a high-risk stock — not yet profitable, and its future rides on its product catching on.